Related Experiment Videos
A new hematopoietic growth factor receptor superfamily: structural features and implications for signal transduction
A D D'Andrea1, G D Fasman, H F Lodish
1Whitehead Institute, Cambridge, Massachusetts.
Current Opinion in Cell Biology
|August 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
Nature communications·2022
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Experimental hematology·2001
The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.
Molecular genetics and metabolism·2001
Modulation of host actin dynamics in pathogenic infections: An emergent perspective.
Current opinion in cell biology·2026
Rabs in the driving seat: Coordinating vesicular traffic and membrane contact site dynamics.
Current opinion in cell biology·2026
Mapping chemoattractant gradients in live tissues.
Current opinion in cell biology·2026
Tribbles pseudokinases: Fine tuning of cell signaling with implications in metabolism, inflammation and cancer.
Current opinion in cell biology·2026
The orchestration of ciliary opus: Interplay of signalling molecules, GTPases, and trafficking machinery.
Current opinion in cell biology·2026
Directing traffic: MAPs, motors, and cellular logistics.
Current opinion in cell biology·2026
Affinity-Activated Protein Switches for Modular and Signal-ON Detection of Small Molecules.
Analytical chemistry·2026
Progress in Natural Product Nanocarriers with Drug-excipient Homology.
Current drug delivery·2026
Isatin-based Strategies for Microbial Infections: A Multifaceted Perspective.
Reviews on recent clinical trials·2026
s-triazine-based Derivatives as Anticancer Agents.
Mini reviews in medicinal chemistry·2026